Eastgate Biotech Corp. (ETBI)
OTCMKTS · Delayed Price · Currency is USD
0.0030
+0.0030 (299,900.00%)
At close: Aug 7, 2025
Eastgate Biotech Market Cap
Eastgate Biotech has a market cap or net worth of $3.17 million as of August 22, 2025. Its market cap has increased by 57.89% in one year.
Market Cap
3.17M
Enterprise Value
n/a
Revenue
137.64K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 5, 2014, Eastgate Biotech's market cap has decreased from 7.91M to 3.17M, a decrease of -59.86%. That is a compound annual growth rate of -7.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 3.17M | -33.33% |
| Dec 23, 2024 | 4.76M | 50.00% |
| Dec 30, 2022 | 3.17M | 11.11% |
| Dec 31, 2021 | 2.86M | -32.50% |
| Dec 30, 2020 | 4.23M | -72.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 632.06M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 366.64M |